Alpha Cognition (ACOG)
9.13
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 Alpha Cognition Inc. For: Jul 31 Filed by: Opaleye Management Inc.
August 4, 2026 4:50 PM - SEC Filing
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
August 3, 2026 8:30 AM - BizWire
Alpha Cognition receives European patent for Alzheimer's drug Zunveyl
July 29, 2026 8:30 AM - StreetInsider
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
July 29, 2026 8:30 AM - BizWire
Form 4 Alpha Cognition Inc. For: Jul 24 Filed by: Opaleye Management Inc.
July 28, 2026 4:05 PM - SEC Filing
Form SCHEDULE 13G/A Alpha Cognition Inc. Filed by: Opaleye Management Inc.
July 24, 2026 4:05 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: Jul 22 Filed by: Opaleye Management Inc.
July 24, 2026 4:05 PM - SEC Filing
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
July 10, 2026 8:30 AM - BizWire
Raymond James Starts Alpha Cognition Inc (ACOG) at Outperform
July 10, 2026 6:05 AM - StreetInsider
Form 4 Alpha Cognition Inc. For: Jun 25 Filed by: Opaleye Management Inc.
June 29, 2026 4:05 PM - SEC Filing
Form SCHEDULE 13G/A Alpha Cognition Inc. Filed by: Opaleye Management Inc.
June 29, 2026 4:05 PM - SEC Filing
Form 8-K Alpha Cognition Inc. For: Jun 16
June 23, 2026 10:36 AM - SEC Filing
Alpha Cognition names Dr. Robert Wills as board chairman
June 23, 2026 8:30 AM - StreetInsider
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
June 23, 2026 8:30 AM - BizWire
Alpha Cognition enrolls first patient in ZUNVEYL Phase 4 study
June 16, 2026 8:33 AM - StreetInsider
Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease
June 16, 2026 8:30 AM - BizWire
Form 4 Alpha Cognition Inc. For: Jun 11 Filed by: Opaleye Management Inc.
June 15, 2026 8:11 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: Jun 09 Filed by: Opaleye Management Inc.
June 11, 2026 4:05 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: Jun 05 Filed by: Opaleye Management Inc.
June 9, 2026 4:06 PM - SEC Filing
Alpha Cognition reports study results for ZUNVEYL in Alzheimer's care
June 9, 2026 8:01 AM - StreetInsider
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
June 9, 2026 8:00 AM - BizWire
Form 4 Alpha Cognition Inc. For: May 27 Filed by: Opaleye Management Inc.
May 29, 2026 7:22 PM - SEC Filing
Maxim Group Starts Alpha Cognition Inc (ACOG) at Buy
May 29, 2026 7:38 AM - StreetInsider
Form 4 Alpha Cognition Inc. For: May 20 Filed by: Opaleye Management Inc.
May 22, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A Alpha Cognition Inc. Filed by: Opaleye Management Inc.
May 22, 2026 4:06 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: May 19 Filed by: D'Angelo Lauren
May 19, 2026 5:02 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: May 15 Filed by: Opaleye Management Inc.
May 19, 2026 4:05 PM - SEC Filing
Alpha Cognition (ACOG) Misses Q1 EPS by 32c
May 14, 2026 5:16 PM - StreetInsider
Alpha Cognition reports Q1 2026 ZUNVEYL revenue of $3.5M, up 40%
May 14, 2026 4:15 PM - StreetInsider
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
May 14, 2026 4:15 PM - BizWire
Form 10-Q Alpha Cognition Inc. For: Mar 31
May 14, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A Alpha Cognition Inc. Filed by: MANCHESTER MANAGEMENT CO LLC
May 12, 2026 7:11 PM - SEC Filing
Full Article List
